Condensed Consolidated Statements of Convertible Preferred Stock and Stockholders’ Equity (Deficit) (Unaudited) - USD ($)	Total	Trinity Warrants	Preferred Stock	Additional Paid-in Capital	Additional Paid-in Capital Trinity Warrants	Accumulated Other Comprehensive Loss	Accumulated Deficit	Common Stock Common Stock	Common Stock Common Stock Trinity Warrants	Common Stock Common Stock SVB Warrants	Class F Stock Common Stock
Beginning balance (in shares) at Dec. 31, 2021	21,671,491
Beginning balance at Dec. 31, 2021	$ 99,470,000
Increase (Decrease) in Temporary Equity [Roll Forward]
Retroactive application of exchange ratio (in shares)	31,407,080
Conversion of convertible preferred stock to common stock (in shares)	53,078,571
Conversion of convertible preferred stock to common stock	$ (99,470,000)
Ending balance (in shares) at Mar. 31, 2022	0
Ending balance at Mar. 31, 2022	$ 0
Balance (in shares) at Dec. 31, 2021			0					27,618,907			8,372,143
Balance at Dec. 31, 2021	(87,533,000)		$ 0	$ 7,949,000		$ (43,000)	$ (95,439,000)	$ 0			$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Retroactive application of exchange ratio (in shares)								40,026,282			12,133,201
Conversion of convertible preferred stock to common stock (in shares)								53,078,571
Conversion of convertible preferred stock to common stock	99,472,000			99,470,000			1,000	$ 1,000
Conversion of class F stock to common stock (in shares)								(20,505,344)			(20,505,344)
Reverse recapitalization, net of transaction costs (in shares)								11,845,943
Reverse recapitalization, net of transaction costs	(33,050,000)			(33,051,000)				$ 1,000
Exercise of warrants (in shares)									237,571	146,954
Exercise of warrants		$ 547,000			$ 547,000
Exercise of stock options (in shares)								511,890
Exercise of stock options	273,000			273,000
Stock-based compensation expense	1,357,000			1,357,000
Unrealized loss on available-for-sale investments	(11,000)					(11,000)
Cumulative Translation Adjustment, Net of Tax, Period Increase (Decrease)	(4,000)					(4,000)
Net income (loss)	41,198,000						41,198,000
Balance (in shares) at Mar. 31, 2022			0					153,971,462			0
Balance at Mar. 31, 2022	$ 22,249,000		$ 0	76,545,000		(58,000)	(54,240,000)	$ 2,000			$ 0
Ending balance (in shares) at Jun. 30, 2022	0
Ending balance at Jun. 30, 2022	$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)								404,167
Exercise of stock options	211,000			211,000
Stock-based compensation expense	2,229,000			2,229,000
Unrealized loss on available-for-sale investments	(37,000)					(37,000)
Cumulative Translation Adjustment, Net of Tax, Period Increase (Decrease)	(8,000)					(8,000)
Net income (loss)	843,000						843,000
Balance (in shares) at Jun. 30, 2022			0					154,442,738			0
Balance at Jun. 30, 2022	25,349,000		$ 0	78,847,000		(103,000)	(53,397,000)	$ 2,000			$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock to LPC (in shares)								21,186
Vesting of early exercised options (in shares)								45,923
Stock Issued During Period, Value, New Issues	50,000			50,000
Stock Issued During Period, Value, Other	38,000			38,000
Consideration to be received on transaction	$ (226,000)			(226,000)
Beginning balance (in shares) at Dec. 31, 2022	0
Beginning balance at Dec. 31, 2022	$ 0
Increase (Decrease) in Temporary Equity [Roll Forward]
Issuance of convertible preferred stock, net of transaction costs (in shares)	100,000
Issuance of convertible preferred stock, net of transaction costs	$ 98,891,000
Ending balance (in shares) at Mar. 31, 2023	100,000
Ending balance at Mar. 31, 2023	$ 98,891,000
Balance (in shares) at Dec. 31, 2022								156,747,708
Balance at Dec. 31, 2022	1,633,000			88,056,000		(366,000)	(86,059,000)	$ 2,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)								96,385
Exercise of stock options	8,000			8,000
Stock-based compensation expense	2,280,000			2,280,000
Unrealized loss on available-for-sale investments	17,000					17,000
Cumulative Translation Adjustment, Net of Tax, Period Increase (Decrease)	20,000					20,000
Net income (loss)	(14,742,000)						(14,742,000)
Balance (in shares) at Mar. 31, 2023								156,844,093
Balance at Mar. 31, 2023	$ (10,784,000)			90,344,000		(329,000)	(100,801,000)	$ 2,000
Beginning balance (in shares) at Dec. 31, 2022	0
Beginning balance at Dec. 31, 2022	$ 0
Ending balance (in shares) at Jun. 30, 2023	100,000
Ending balance at Jun. 30, 2023	$ 98,891,000
Balance (in shares) at Dec. 31, 2022								156,747,708
Balance at Dec. 31, 2022	$ 1,633,000			88,056,000		(366,000)	(86,059,000)	$ 2,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)	128,923
Balance (in shares) at Jun. 30, 2023								158,244,189
Balance at Jun. 30, 2023	$ (22,685,000)			92,648,000		(344,000)	(114,991,000)	$ 2,000
Beginning balance (in shares) at Mar. 31, 2023	100,000
Beginning balance at Mar. 31, 2023	$ 98,891,000
Ending balance (in shares) at Jun. 30, 2023	100,000
Ending balance at Jun. 30, 2023	$ 98,891,000
Balance (in shares) at Mar. 31, 2023								156,844,093
Balance at Mar. 31, 2023	(10,784,000)			90,344,000		(329,000)	(100,801,000)	$ 2,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)								1,570,599
Exercise of stock options	5,000			5,000
Stock-based compensation expense	2,362,000			2,362,000
Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation	(63,000)			(63,000)
Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation								(170,503)
Unrealized loss on available-for-sale investments	(11,000)					(11,000)
Cumulative Translation Adjustment, Net of Tax, Period Increase (Decrease)	(4,000)					(4,000)
Net income (loss)	(14,190,000)						(14,190,000)
Balance (in shares) at Jun. 30, 2023								158,244,189
Balance at Jun. 30, 2023	$ (22,685,000)			$ 92,648,000		$ (344,000)	$ (114,991,000)	$ 2,000